These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 16055958)

  • 21. Lipodystrophy in HIV/AIDS: a comparison between physically active, and inactive HIV-infected vs. uninfected men.
    DE Matos CV; Farinatti P; Lopes KG; Borges JP
    J Sports Med Phys Fitness; 2024 Nov; 64(11):1217-1223. PubMed ID: 39101407
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The frequency of low muscle mass and its overlap with low bone mineral density and lipodystrophy in individuals with HIV--a pilot study using DXA total body composition analysis.
    Buehring B; Kirchner E; Sun Z; Calabrese L
    J Clin Densitom; 2012; 15(2):224-32. PubMed ID: 22169198
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pronounced lipoatrophy in HIV-infected men receiving HAART for more than 6 years compared with the background population.
    Hansen AB; Lindegaard B; Obel N; Andersen O; Nielsen H; Gerstoft J
    HIV Med; 2006 Jan; 7(1):38-45. PubMed ID: 16313291
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduced intravertebral bone marrow fat in HIV-infected men.
    Huang JS; Mulkern RV; Grinspoon S
    AIDS; 2002 Jun; 16(9):1265-9. PubMed ID: 12045492
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Normalization of fat accrual in lipoatrophic, HIV-infected children switched from stavudine to tenofovir and from protease inhibitor to efavirenz.
    Viganò A; Brambilla P; Cafarelli L; Giacomet V; Borgonovo S; Zamproni I; Zuccotti G; Mora S
    Antivir Ther; 2007; 12(3):297-302. PubMed ID: 17591019
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Body composition and lipodystrophy in prepubertal HIV-infected children.
    Palchetti CZ; Patin RV; Gouvêa Ade F; Szejnfeld VL; Succi RC; Oliveira FL
    Braz J Infect Dis; 2013; 17(1):1-6. PubMed ID: 23318286
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Surrogate markers of visceral adipose tissue in treated HIV-infected patients: accuracy of waist circumference determination.
    Falutz J; Rosenthall L; Kotler D; Zona S; Guaraldi G
    HIV Med; 2014 Feb; 15(2):98-107. PubMed ID: 24112443
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sex-specific fat mass ratio cutoff value identifies a high prevalence of cardio-metabolic disorders in people living with HIV.
    Barale M; Massano M; Bioletto F; Maiorino F; Pusterla A; Mazzetti R; Trentini L; Bonora S; Di Perri G; Ghigo E; Procopio M
    Nutr Metab Cardiovasc Dis; 2022 Aug; 32(8):1936-1943. PubMed ID: 35680489
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Highly active antiretroviral-treated HIV-infected children show fat distribution changes even in absence of lipodystrophy.
    Brambilla P; Bricalli D; Sala N; Renzetti F; Manzoni P; Vanzulli A; Chiumello G; di Natale B; Viganò A
    AIDS; 2001 Dec; 15(18):2415-22. PubMed ID: 11740192
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of dual-energy X-ray absorptiometry machines for measuring fat distribution changes of HIV-associated lipodystrophy.
    Yang Y; Zhu WD; Paton NI
    Antivir Ther; 2004 Oct; 9(5):771-8. PubMed ID: 15535415
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of discontinuing stavudine or protease inhibitor therapy on human immunodeficiency virus-related fat redistribution evaluated by dual-energy x-ray absorptiometry.
    Tavassoli N; Bagheri H; Sommet A; Delpierre C; Marion-Latard F; Massip P; Aquilina C; Bonnet E; Obadia M; Labau E; Montastruc JL; Bernard J
    Pharmacotherapy; 2006 Feb; 26(2):154-61. PubMed ID: 16466321
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reproducibility of DXA estimations of body fat in HIV lipodystrophy: implications for clinical research.
    Cavalcanti RB; Cheung AM; Raboud J; Walmsley S
    J Clin Densitom; 2005; 8(3):293-7. PubMed ID: 16055959
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HIV-Infected Patients With and Without Lipodystrophy Under Combined Antiretroviral Therapy: Evaluation of Body Composition.
    Grenha I; Oliveira J; Lau E; Santos AC; Sarmento A; Pereira J; Carvalho D; Freitas P
    J Clin Densitom; 2018; 21(1):75-82. PubMed ID: 28034590
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Body composition in HIV-infected patients receiving highly active antiretroviral therapy.
    Chițu-Tișu CE; Barbu EC; Lazăr M; Bojincă M; Tudor AM; Hristea A; Abagiu AO; Ion DA; Bădărău AI
    Acta Clin Belg; 2017 Feb; 72(1):55-62. PubMed ID: 27724840
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Switching from zidovudine/lamivudine to tenofovir/emtricitabine improves fat distribution as measured by fat mass ratio.
    Martínez E; Ribera E; Clotet B; Estrada V; Sanz J; Berenguer J; Rubio R; Pulido F; Larrousse M; Curran A; Negredo E; Arterburn S; Ferrer P; Álvarez ML
    HIV Med; 2015 Jul; 16(6):370-4. PubMed ID: 25496141
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A syndrome of peripheral fat wasting (lipodystrophy) in patients receiving long-term nucleoside analogue therapy.
    Saint-Marc T; Partisani M; Poizot-Martin I; Bruno F; Rouviere O; Lang JM; Gastaut JA; Touraine JL
    AIDS; 1999 Sep; 13(13):1659-67. PubMed ID: 10509567
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adipocyte-derived hormone levels in HIV lipodystrophy.
    Kosmiski L; Kuritzkes D; Lichtenstein K; Eckel R
    Antivir Ther; 2003 Feb; 8(1):9-15. PubMed ID: 12713059
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship of body composition with bone mineral density in northern Chinese men by body mass index levels.
    Kang D; Liu Z; Wang Y; Zhang H; Feng X; Cao W; Wang P
    J Endocrinol Invest; 2014 Apr; 37(4):359-67. PubMed ID: 24477947
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Growth hormone-releasing hormone in HIV-infected men with lipodystrophy: a randomized controlled trial.
    Koutkia P; Canavan B; Breu J; Torriani M; Kissko J; Grinspoon S
    JAMA; 2004 Jul; 292(2):210-8. PubMed ID: 15249570
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of highly active antiretroviral therapy on fat, lean, and bone mass in HIV-seropositive men and women.
    McDermott AY; Shevitz A; Knox T; Roubenoff R; Kehayias J; Gorbach S
    Am J Clin Nutr; 2001 Nov; 74(5):679-86. PubMed ID: 11684538
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.